Atlas FDA

Bulkamid Urethral Bulking System

FDA premarket approval P170023/S005 · decided 2020-12-02

Approval details

PMA number
P170023
Supplement
S005
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Bulkamid Urethral Bulking System
Generic name
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant
Boston Scientific Corporation
Date received
2020-09-04
Decision date
2020-12-02
Days to decision
89 days
Decision code
APPR
Product code
LNM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Marlborough, MA
Statement
Approval for minor changes to the Bulkamid Needle, including a change in the manufacturer for the Bulkamid Needle, which includes minor changes to the needle hubs outershape, the raw materials used for the needle hub and sterile barrier system (pouch), and the dimensions of the needle pouch.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27